Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision history now shows a new version (v3.6.5) replacing the previous v3.6.4, indicating a site update. This is a metadata update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3 in the footer. This reflects a new software release/build reference for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check54 days agoChange DetectedThe history now indicates a new site revision: v3.6.3 replaces the previous v3.6.2. This reflects a routine site update rather than any change to the study information.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page footer now shows Revision: v3.6.2. This indicates a new build/version of the page rather than changes to the study record.SummaryDifference0.0%

- Check75 days agoChange DetectedThe record history adds a note that the study is no longer looking for participants and updates the revision to v3.6.0, replacing the prior v3.5.5 entry.SummaryDifference0.1%

- Check82 days agoChange DetectedThe Record History now shows Revision: v3.5.5 in place of Revision: v3.5.4. This update reflects a new site release/version label rather than changes to the study data or page content.SummaryDifference0.0%

Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.